Multicenter phase II study with docetaxel, 5-FU, leucovorin, and oxaliplatin in patients with metastatic or locally advanced gastric cancer or cancer of the esophagogastric junction- FLOT
- Conditions
- Metastatic or locally advanced gastric cancer
- Registration Number
- EUCTR2005-004135-22-DE
- Lead Sponsor
- Krankenhaus Nordwest
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 42
Inclusion Criteria
Patients with advanced gastric cancer
Sufficient bone marrow and organ function
Age >= 18 years; women and men
ECOG 0, 1, or 2
written informed concent
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Known allergy to any study drug
Participation at another clinical investigation
Severe concurrent illness
Gravidity
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method